EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors

Xiong Zhang, Yatian Yang, Hongye Zou, Yang Yang, Xingling Zheng, Eva Corey, Amina Zoubeidi, Nicolas Mitsiades, Ai-Ming Yu, Yuanpei Li, Hong-Wu Chen

Acta Pharmaceutica Sinica B · 2025-03 · 15 (3) · 1415-1429

DOI: 10.1016/j.apsb.2025.01.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-03. Verfasst von Xiong Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NCI NIH HHS, Office of Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AZD5153BRD4BRN2ChIP-seqFOXA1NeurogenesisPDXTumor lineage plasticity

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
  • Department of Urology, University of Washington, Seattle, DC 98915, USA.
  • Department of Urologic Sciences, University of British Columbia, Vancouver, BC V5Z1M9, Canada.
  • Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
  • Comprehensive Cancer Center, University of California Davis, Sacramento, CA 95817, USA.
  • VA Northern California Health Care System-Mather, Mather, CA 95655, USA.

Förderung

  • BLRD VA
  • NCI NIH HHS
  • Office of Research and Development
  • DOD
  • National Cancer Institute
  • Prostate Cancer Foundation
  • NIH
  • Comprehensive Cancer Center, University of California, Davis

Zitieren

APA

Zhang, X., Yang, Y., Zou, H., Yang, Y., Zheng, X., Corey, E., Zoubeidi, A., Mitsiades, N., Yu, A. M., Li, Y., & Chen, H. W. (2025). Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors. Acta Pharmaceutica Sinica B, 15(3), 1415-1429. https://doi.org/10.1016/j.apsb.2025.01.007

Vancouver

Zhang X, Yang Y, Zou H, Yang Y, Zheng X, Corey E, et al. Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors. Acta Pharmaceutica Sinica B. 2025;15(3):1415-1429. doi:10.1016/j.apsb.2025.01.007

BibTeX
@article{Zhang2025,
  author = {Zhang, Xiong and Yang, Yatian and Zou, Hongye and Yang, Yang and Zheng, Xingling and Corey, Eva and Zoubeidi, Amina and Mitsiades, Nicolas and Yu, Ai-Ming and Li, Yuanpei and Chen, Hong-Wu},
  title = {Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2025},
  volume = {15},
  number = {3},
  pages = {1415--1429},
  doi = {10.1016/j.apsb.2025.01.007}
}
Kostenlos starten →